The Globe and Mail
🏢 Globe and Mail Inc. (Woodbridge)
Jun 10, 2026
· 6 min read
Quick Score
○ Unverifiable
View full audit trail →
Apotex soars as private equity firm builds on legacy of founder Barry Sherman
Original article ↗ 🔒 Paywalled source — limited preview availableB.I.A.S. ANALYSIS
CENTER LEFT
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
-0.70 · CENTER
ML v2 (DistilBERT)
0.266 · RIGHT
Ensemble
-0.217 · CENTER LEFT
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.104
10,358 articles tracked
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
Subscribe to see claim-by-claim verdicts and reasoning.
Article Excerpt
ANALYSIS
Apotex soars as private equity firm builds on legacy of founder Barry Sherman
ANDREW WILLIS
PUBLISHED JUNE 10, 2026
Open this photo in gallery:
Apotex stock finished its first day of trading on Wednesday at $27, up $3 from the IPO price in an otherwise down market.
SAMMY KOGAN/THE GLOBE AND MAIL
COMMENTS
SHARE
SAVE FOR LATER
Listen to this article
Learn more about audio
Log in or create a free account to listen to this article.
Apotex Health Corp. founder Barry Sherman left his four children a tidy fortune, estimated at $4-billion, when he and his wife Honey were murdered nearly…
Read full article at The Globe and Mail ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.